Frienson Pradhan | Molecular Biology | Young Scientist Award

Published on by Medical Lab Scientist

Mr. Frienson Pradhan | Molecular Biology | Young Scientist Award

Kathmandu University | Nepal

Mr. Frienson Pradhan is a biotechnology researcher with strong interdisciplinary training in molecular biology, microbiology, immunology, and bioinformatics, with a primary focus on translational and sustainability-driven research. His work spans host biomarker discovery, nature-based bioactive compounds, and applied environmental biotechnology. He has led and contributed to studies on circulating miR-1246 as a diagnostic and prognostic biomarker in dengue infection, integrating molecular diagnostics, RT-qPCR, and statistical correlation analyses, culminating in a peer-reviewed publication. His research portfolio further includes investigations into plant-derived antibacterial and biopesticidal agents, phylogenetic and domain analysis of bitter taste receptors (TAS2R), and physico-chemical and microbial assessment of drinking water quality. Actively engaged in collaborative and funded research initiatives, he has supported projects linking laboratory science with sustainable enterprise development. His research excellence has been internationally recognized through competitive scientific awards and global research forums, reflecting a strong commitment to impactful, innovation-driven biotechnology research.

View ORCID Profile

Featured Publications

Alina Ecaterina Jucan | Molecular Biology | Research Excellence Award

Published on by Medical Lab Scientist

Dr. Alina Ecaterina Jucan | Molecular Biology | Research Excellence Award

Doctor | University of Medicine and Pharmacy | Romania

Dr. Alina Ecaterina Jucan is a research-oriented scholar whose work contributes to the advancement of her field through focused investigation and peer-reviewed dissemination. Her academic output comprises 7 published documents, reflecting consistent engagement with scholarly research and evidence-based inquiry. These publications have collectively received 51 citations, indicating growing recognition and uptake of her findings within the research community. With an h-index of 4, her work demonstrates both productivity and measurable impact, highlighting publications that have achieved sustained citation performance. Her research emphasizes methodological rigor, analytical clarity, and relevance to current scientific and clinical questions, contributing to the broader body of knowledge and supporting translational relevance where applicable. Through her publications, she has addressed emerging challenges, refined existing concepts, and added incremental value to ongoing academic discourse. Her citation metrics underscore the visibility and influence of her research outputs, positioning her as an active contributor to her domain with a developing and credible scholarly profile grounded in peer-reviewed research excellence.

Citation Metrics (Scopus)

60

45

30

15

0

 

51
Citations

7
Documents

4
h-index

Citations

Documents

h-index

Featured Publications

Yazan Zedan | Molecular Biology | Young Scientist Award

Published on by Medical Lab Scientist

Mr. Yazan Zedan | Molecular Biology | Young Scientist Award

Postgraduate Student | Novosibirsk State University | Russia

Mr. Yazan Zedan is a molecular biology researcher specializing in translational biomedical sciences, with a strong focus on biomarker discovery, molecular diagnostics, and clinical assay development. His research integrates molecular biology, biotechnology, and medical physics to advance non-invasive diagnostic strategies for complex diseases. He has contributed to interdisciplinary studies spanning miRNA profiling, cancer biomarker validation, and translational clinical research, emphasizing the bridge between laboratory discovery and real-world clinical application. His academic training encompasses biomedical sciences, medical biotechnology, and molecular biology, providing a robust foundation for experimental design, data interpretation, and translational innovation. His scholarly work reflects a commitment to precision medicine and evidence-based diagnostics, particularly in oncology and molecular pathology.

Featured Publications

Heming Li | Molecular Biology | Research Excellence Award

Published on by Medical Lab Scientist

Dr. Heming Li | Molecular Biology | Research Excellence Award

Doctor | The first hospital of China Medical University | China

Dr. Heming Li is an oncology clinician-scientist whose research has generated 1,045 citations across 37 scientific documents with an h-index of 17, reflecting a sustained impact on translational cancer science. His work centers on liquid biopsy innovations, particularly circulating tumor cells (CTCs), tumor invasion and metastasis, and immunotherapy biomarkers in lung, gastric, and hepatobiliary cancers. Dr. Li is recognized for pioneering one of China’s earliest and most sensitive cell-surface vimentin (CSV)–based CTC detection platforms, integrating negative and positive enrichment to enhance diagnostic accuracy, reduce costs, and enable real-time monitoring of tumor evolution. His research spans EMT regulation, immune escape, metabolic reprogramming, and multi-omics characterization of metastatic pathways, leading to first-author and corresponding-author publications in high-impact journals such as The Lancet, Journal of Hematology & Oncology, Journal of Experimental & Clinical Cancer Research, Molecular Cancer, Cancer Letters, and Cell Death & Disease. He has elucidated mechanisms including IGF-IR signaling, KDM4A/STAT3-driven tumor progression, ICAM-1-mediated microenvironmental adaptation, and PD-L1 expression on CSV⁺ CTCs as a prognostic marker in gastric cancer. His recent studies have also advanced understanding of FGL1 as an immune checkpoint target and the biological significance of TROP2 in cancer therapeutics. As principal investigator, he has secured major national and provincial funding, including NSFC General and Young Programs, to study CTC-based biomarkers, immunotherapy prediction models, and metastasis-driving pathways. Through sustained contributions across liquid biopsy technology, molecular oncology, and clinically actionable biomarker development, Dr. Li has established a leading research profile shaping the future of precision cancer care.

Profile: Scopus  

Featured Publications